Biomaterials-Enabled Antithrombotics: Recent Advances and Emerging Strategies | Molecular Pharmaceutics
![Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants | Journal of Medicinal Chemistry Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm020578e/asset/images/large/jm020578en00001.jpeg)
Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants | Journal of Medicinal Chemistry
![JCDD | Free Full-Text | Antithrombotic Treatment and Its Association with Outcome in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients JCDD | Free Full-Text | Antithrombotic Treatment and Its Association with Outcome in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients](https://www.mdpi.com/jcdd/jcdd-09-00366/article_deploy/html/images/jcdd-09-00366-g001.png)
JCDD | Free Full-Text | Antithrombotic Treatment and Its Association with Outcome in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients
![Antithrombotics for secondary prevention of noncardioembolic ischaemic stroke | Nature Reviews Neurology Antithrombotics for secondary prevention of noncardioembolic ischaemic stroke | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrneurol.2012.33/MediaObjects/41582_2012_Article_BFnrneurol201233_Fig1_HTML.jpg)
Antithrombotics for secondary prevention of noncardioembolic ischaemic stroke | Nature Reviews Neurology
![The ACTIV-4b Trial: Antithrombotics For Treatment of Outpatient COVID-19 - REBEL EM - Emergency Medicine Blog The ACTIV-4b Trial: Antithrombotics For Treatment of Outpatient COVID-19 - REBEL EM - Emergency Medicine Blog](https://rebelem.com/wp-content/uploads/2022/01/ACTIV-4b-1024x575.png)
The ACTIV-4b Trial: Antithrombotics For Treatment of Outpatient COVID-19 - REBEL EM - Emergency Medicine Blog
![Pharmacy | Free Full-Text | Practical Guide for Anticoagulant and Antiplatelet Reversal in Clinical Practice Pharmacy | Free Full-Text | Practical Guide for Anticoagulant and Antiplatelet Reversal in Clinical Practice](https://www.mdpi.com/pharmacy/pharmacy-11-00034/article_deploy/html/images/pharmacy-11-00034-g001.png)
Pharmacy | Free Full-Text | Practical Guide for Anticoagulant and Antiplatelet Reversal in Clinical Practice
![Impact of different antithrombotics on the microcirculation and viability of perforator-based ischaemic skin flaps in a small animal model | Scientific Reports Impact of different antithrombotics on the microcirculation and viability of perforator-based ischaemic skin flaps in a small animal model | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep35833/MediaObjects/41598_2016_Article_BFsrep35833_Fig1_HTML.jpg)
Impact of different antithrombotics on the microcirculation and viability of perforator-based ischaemic skin flaps in a small animal model | Scientific Reports
![Antithrombotic Medication Use and Bleeding Risk in Medically Ill Patients After Hospitalization - Charles E. Mahan, Alex C. Spyropoulos, Maxine D. Fisher, Larry E. Fields, Roger M. Mills, Judith J. Stephenson, An-Chen Antithrombotic Medication Use and Bleeding Risk in Medically Ill Patients After Hospitalization - Charles E. Mahan, Alex C. Spyropoulos, Maxine D. Fisher, Larry E. Fields, Roger M. Mills, Judith J. Stephenson, An-Chen](https://journals.sagepub.com/cms/10.1177/1076029612470967/asset/images/large/10.1177_1076029612470967-fig2.jpeg)
Antithrombotic Medication Use and Bleeding Risk in Medically Ill Patients After Hospitalization - Charles E. Mahan, Alex C. Spyropoulos, Maxine D. Fisher, Larry E. Fields, Roger M. Mills, Judith J. Stephenson, An-Chen
![Direct Oral Anticoagulants and Coronary Artery Disease | Arteriosclerosis, Thrombosis, and Vascular Biology Direct Oral Anticoagulants and Coronary Artery Disease | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/e00b6094-e79e-4ba6-b2be-cfcff9e17804/atvbaha.121.317171.fig02.jpg)
Direct Oral Anticoagulants and Coronary Artery Disease | Arteriosclerosis, Thrombosis, and Vascular Biology
![Frontiers | Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches Frontiers | Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches](https://www.frontiersin.org/files/Articles/805525/fcvm-09-805525-HTML/image_m/fcvm-09-805525-g001.jpg)
Frontiers | Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches
![IJERPH | Free Full-Text | Multiple Medication Adherence and Related Outcomes in Community-Dwelling Older People on Chronic Polypharmacy: A Retrospective Cohort Study on Administrative Claims Data IJERPH | Free Full-Text | Multiple Medication Adherence and Related Outcomes in Community-Dwelling Older People on Chronic Polypharmacy: A Retrospective Cohort Study on Administrative Claims Data](https://www.mdpi.com/ijerph/ijerph-19-05692/article_deploy/html/images/ijerph-19-05692-g001-550.jpg)
IJERPH | Free Full-Text | Multiple Medication Adherence and Related Outcomes in Community-Dwelling Older People on Chronic Polypharmacy: A Retrospective Cohort Study on Administrative Claims Data
![Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment Failure | Stroke Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment Failure | Stroke](https://www.ahajournals.org/cms/asset/7d20a7ee-2e76-4393-a666-e2789d751310/strokeaha.121.034622.fig02.jpg)
Antithrombotic Therapy for Stroke Prevention in Patients With Ischemic Stroke With Aspirin Treatment Failure | Stroke
Piericones A and B as Potent Antithrombotics: Nanomolar Noncompetitive Protein Disulfide Isomerase Inhibitors with an Unexpected Chemical Architecture | Journal of the American Chemical Society
![JCDD | Free Full-Text | Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment JCDD | Free Full-Text | Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment](https://www.mdpi.com/jcdd/jcdd-09-00397/article_deploy/html/images/jcdd-09-00397-g001.png)
JCDD | Free Full-Text | Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment
![Platelet-Mimicking Nanosponges for Functional Reversal of Antiplatelet Agents | Circulation Research Platelet-Mimicking Nanosponges for Functional Reversal of Antiplatelet Agents | Circulation Research](https://www.ahajournals.org/cms/asset/b0877316-c3be-498f-90d6-a21a9145b8d6/circresaha.122.321034.fig08.jpg)